Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

Sterile Assurance Level Explained

YouTube video thumbnail

What does a sterile assurance level actually mean, and how do you prove sterilization worked? In this Bio Break episode, Nick and Nigel walk through how terminally sterilized medical devices are verified, what methods are used to sterilize them, and how biological indicators are used to challenge the process in the hardest-to-reach places.

Terminally Sterilized Devices and Common Methods

Many medical devices that cross Nick and Nigel’s desk are sterile disposables. Devices sterilized at the end of their production process are called terminally sterilized. The common accepted sterilization methods are ETO, a gas that permeates through sterile barrier packaging and kills microorganisms throughout the device, and radiation, which includes electron beam, X-ray, and gamma radiation that pass through materials and destroy microorganisms as they go.

Why Device Geometry Creates Sterilization Challenges

Each method has its challenges depending on device geometry. Devices with long lumens, essentially internal tubes, present a particular difficulty. ETO gas has to make its way into the center on its own without being forced in, which takes time and isn’t always straightforward. Radiation can sometimes be better suited for long lumens, though not always. Adapting the sterilization approach to the shape of the device is part of the validation work.

Biological Indicators: Proving the Process Worked

Verifying that sterilization actually reached the most difficult areas is Nigel’s domain as a microbiologist. Biological indicators, which are bacterial spores, are placed in challenging locations such as the center of a long lumen. After sterilization, they are taken to the lab and incubated. If any growth appears, the sterilization didn’t work.

For radiation sterilization, the dose level can also be measured at the point of interest, though getting instruments into tight geometries can be its own challenge. In some cases an analog approach is used, and final product testing for bacterial remnants is another option.

What SAL 6 Actually Means

The target for terminally sterilized devices is sterility assurance level six, or SAL 6. Nick describes this as roughly a one in a million probability that any viable microorganisms remain after sterilization, equivalent to a 99.9999 percent chance that they were all eliminated. That statistical benchmark is the level the team shoots for.

What this episode covers

  • What terminally sterilized means and why many disposable medical devices fall into this category
  • The two common sterilization methods: ETO gas, which permeates sterile barrier packaging and kills microorganisms throughout the device, and radiation including electron beam, X-ray, and gamma, which pass through materials and destroy microorganisms as they go
  • Why device geometry, particularly long lumens, creates challenges for both gas and radiation sterilization methods
  • How biological indicators, which are bacterial spores placed in difficult-to-reach locations, are used to verify that sterilization worked, and what it means if growth appears after incubation
  • Additional verification approaches including radiation dose measurement, analog methods, and final product testing for bacterial remnants
  • Nick’s explanation of SAL 6 as approximately a one in a million probability that viable microorganisms remain, equivalent to a 99.9999 percent elimination rate
Businessman holding a glowing compliance icon with legal and regulatory symbols, representing REACH SVHC compliance for medical device manufacturers

Nigel Syrotuck breaks down REACH SVHC compliance for teams working with material suppliers and compliance questionnaires.

Medical Device Design Simulation

We examine when computational modelling and simulation, or CM&S, genuinely supports medical device simulation strategy and when it becomes a costly detour.

Transparent medical device prototype surrounded by computational simulation mesh representing modeling and simulation during medical device development.

Many teams still underuse CM&S, often bringing it late in device validation, when key decisions have already been made. That approach leaves much of the value of CM&S untapped.

Biomedical engineer reviewing a thermal simulation of human head tissue on a monitor, color-mapped from warm to cool gradients

This article traces the Pennes bioheat equation from its 1948 origins to modern multiscale approaches, explaining how engineers select the right level of modelling complexity across device categories.